Past Podcast Episodes

Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. My guest is the founder and CEO of iQuity, Dr. Chase Spurlock. iQuity is using its expertise in machine learning to improve patient care, drive the creation of new therapies, and reduce the costs associated with managing chronic illness, including multiple sclerosis.

We're also talking about the important but sometimes overlooked difference between MS facts and MS beliefs. We'll tell you about the safety alert that the FDA has issued for Lemtrada, and new survey research from the MS Society in the UK that shows the majority of people living with MS are living with feelings of loneliness and isolation.

You'll hear about new study data that shows the gender differences in MS have some age-related fine points that are worth noting, and we'll tell you about a Phase 3 clinical trial that's looking at the effectiveness of high-dose biotin in slowing or stopping MS progression for people living with progressive MS.

We have a lot to talk about! Are you ready for RealTalk MS?!

___________

The Difference Between MS Facts & MS Beliefs 0:22

How AI is About to Disrupt Healthcare 4:21

FDA Issues a Safety Alert for Lemtrada 7:40

MS Society in the UK Survey Research Shows 3 in 5 People Living with MS are Living with Loneliness 9:51

Gender Differences in MS Vary with Age & MS Subtype 13:40

MedDay Phase 3 Clinical Trial for Progressive MS Fully Enrolled 15:55

My Interview with iQuity CEO, Dr. Chase Spurlock 17:50

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes
in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

FDA Warns About Rare But Serious Risks of Stroke & Blood Vessel Wall Tears with Multiple Sclerosis Drug Lemtrada

Age-Dependent Variation of Female Preponderance Across Different Phenotypes of Multiple Sclerosis: A Retrospective Cross-Sectional Study

iQuity

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 68
Hosted By: Jon Strum
Guest: Dr. Chase Spurlock

Tags: MS, MultipleSclerosis, MS, RealTalkMS, mssocietyUK, AI, Lemtrada, MedDay, Biotin, iQuity

Research is the engine that drives us toward better understanding MS, better treating MS, and one day, curing MS. My guest on the podcast is Dr. Larry Sherman, who plays a vital role on the front lines of MS research. We're talking with Dr. Sherman about some of his most significant research and his unique research lab.

We're also talking about two important victories for MS Activists. We'll tell you about the EMA approval of Gilenya for treating pediatric MS, the FDA approval of a generic for Aubagio, new technology that will enable people with MS to pilot their wheelchairs by flexing a couple of facial muscles, and the rehab technique that can benefit Olympic athletes and people living with MS.

We have a lot to talk about! Are you ready for RealTalk MS?!

___________

MS Activists Have Something to Celebrate 0:22

National Neurological Conditions Surveillance System Will Study Data for MS 4:48

European Medicines Agency Approves Gilenya for Pediatric MS 6:41

FDA Approves Generic for Aubagio 8:21

New Technology Lets You Pilot a Wheelchair By Flexing Facial Muscles 9:32

Motor Imagery with Verbal Cues & Music May Lead to Improved Walking, Fatigue & Quality of Life for People Living with MS 11:31

My Interview with Dr. Larry Sherman 15:34

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes
in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

National MS Society: Get Involved & Advocate For Change

Limbitless Solutions Project Xavier

STUDY: Effects and Mechanisms of Differently Cued and Non-Cued Motor Imagery in People with Multiple Sclerosis: A Randomised Controlled Trial

Oregon National Primate Research Center

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 67
Hosted By: Jon Strum
Guest: Dr. Larry Sherman

Tags: MS, MultipleSclerosis, MSsociety, ACA, MSActivist, Gilenya, Aubagio, Limbitless3D, RealTalkMS